131 related articles for article (PubMed ID: 7611832)
1. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis and H2-antihistaminic effect of N,N'-bisheteroaryl N,N'-bisheteroaryl-substituted cyanoguanidines and 2-nitro-1,1-ethenediamines. 17. H2-antihistaminics].
Borchers A; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1984; 34(7):751-4. PubMed ID: 6149751
[TBL] [Abstract][Full Text] [Related]
3. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
Ishikawa H; Ito H; Higaki M; Higaki M; Matsumoto Y; Kamimura T; Katsura Y; Tomishi T; Inoue Y; Takasugi H; Tomoi M; Krakowka S; Yoshida K
Eur J Pharmacol; 1999 Aug; 378(3):299-310. PubMed ID: 10493106
[TBL] [Abstract][Full Text] [Related]
4. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
[TBL] [Abstract][Full Text] [Related]
5. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
6. Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.
Katsura Y; Inoue Y; Tomishi T; Ishikawa H; Takasugi H
J Med Chem; 1994 Jan; 37(1):57-66. PubMed ID: 7904648
[TBL] [Abstract][Full Text] [Related]
7. [Isohistamine and homologs as components of H2-antagonists. 22. H2-antihistaminics].
Buschauer A; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1985; 35(7):1025-9. PubMed ID: 2864932
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis and antiulcer activity of N-2-(2-hydroxy-2-phenyl)ethyl-N"-(methanesulfonyl)guanidine analogue of ranitidine. Development of a new antiulcer agent T-593].
Shibata H; Kusayanagi Y; Arai H; Hashiba K; Yamamoto Y; Onoda M
Yakugaku Zasshi; 1998 Mar; 118(3):88-104. PubMed ID: 9549432
[TBL] [Abstract][Full Text] [Related]
9. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):49-54. PubMed ID: 6112034
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
11. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and h2-antihistaminic activity of n,n'-bisimidazole-substituted thioureas, cyanoguanidines and 2-nitro-1,1-ethenediamines 10. C: H2-antihistaminics].
Borchers A; Engler H; Szelenyi I; Schunack W
Arzneimittelforschung; 1982; 32(12):1509-12. PubMed ID: 6130774
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine.
Li L; Kracht J; Peng S; Bernhardt G; Elz S; Buschauer A
Bioorg Med Chem Lett; 2003 May; 13(10):1717-20. PubMed ID: 12729649
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures].
Schulze FR; Alisch RA; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1994 Jul; 327(7):455-62. PubMed ID: 7915515
[TBL] [Abstract][Full Text] [Related]
15. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and dual histamine H₁ and H₂ receptor antagonist activity of cyanoguanidine derivatives.
Sadek B; Alisch R; Buschauer A; Elz S
Molecules; 2013 Nov; 18(11):14186-202. PubMed ID: 24248146
[TBL] [Abstract][Full Text] [Related]
17. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
18. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the novel H2 antagonist famotidine: in vitro studies.
Bertaccini G; Coruzzi G; Poli E; Adami M
Agents Actions; 1986 Nov; 19(3-4):180-7. PubMed ID: 2881455
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
